A global online study of haematopoietic stem cell transplantation in multiple sclerosis and other neurodegenerative disorders.

ABSTRACT:

Background

The objective of this study was to understand the uptake of hemopoietic stem cell transplantation (HSCT) in neuroimmunological disorders like multiple sclerosis (MS).

Method

An independent University affiliated research organization conducted a global online survey of people having had HSCT, examining demographics, treatment protocol, and effectiveness.

Results

Of 271 participants, useful data were available in 223; women aged 35-54 accounted for 73.5%. Most had a household income greater than US$50,000, and the majority of participants were from Australia and the United States. Nearly 94.6% of people suffer from MS. Most had their treatment in Russia (38.7%) and 78.1% had nonmyeloablative transplants. Nearly half of the participants spent between US$50,000

SUBMITTER: Panegyres PK 

PROVIDER: S-EPMC10011666 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature